Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus fentanyl added to lidocaine paracervical block for pain control during curettage
IRCT20141209020258N162Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Apr 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial comparing Lidocaine + dexmedetomidine paracervical block with Lidocaine + fentanyl paracervical block (2 arms). Primary endpoints: Pain, Nausea and vomiting and 1 more. Started Apr 2021; status: completed.
02
Drugs
dexmedetomidinefentanyllidocaine
Beyond the preview
Go deeper on IRCT20141209020258N162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141209020258N162.